A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
11/2011
11/09/2011	CN102233060A Baihuawang liquid and use thereof
11/09/2011	CN102233058A Medicament capable of alleviating nausea, vomit and poor appetite caused by radiotherapy and chemotherapy
11/09/2011	CN102233054A Traditional Chinese medicine for treating rhinocarcinoma
11/09/2011	CN102233023A Method for preparing hedyotis chrysotricha total alkaloid
11/09/2011	CN102233019A Biailing
11/09/2011	CN102233017A Method for extracting apple polyphenol by using cutinase, and application thereof
11/09/2011	CN102233013A Preparation method for total saponins of pulsatilla chinensis
11/09/2011	CN102233012A Chinese medicine for treating rhinocarcinoma
11/09/2011	CN102233004A Drug for treating liver diseases
11/09/2011	CN102232999A Traditional Chinese medicine for treating rhinocarcinoma
11/09/2011	CN102232995A Preparation method of total flavonoids in medicago sativa L.
11/09/2011	CN102232994A Method for preparing total phenols of Lignum Sappan
11/09/2011	CN102232990A Gynostemma pentaphylla blood tonifying nutrient solution and preparation method thereof
11/09/2011	CN102232988A Total saponins of psammosilene tunicoids (TSPT) with antitumor activity, and preparation thereof
11/09/2011	CN102232977A Method for extracting total saponins from pokeberry root
11/09/2011	CN102232973A Compound bacterial suspension
11/09/2011	CN102232972A Preparation method of whole cell suspension of streptococcus pyogenes and serratia marcescens
11/09/2011	CN102232963A Method for establishing ulcerative colitis chemically cancer-induced animal model
11/09/2011	CN102232962A Composition containing astragaloside active components as well as preparation method and application thereof
11/09/2011	CN102232960A Epigallocatechin gallate (ECG) and daunorubicin (DNR) composition and use thereof
11/09/2011	CN102232959A Method for reducing daunorubicin cardiac toxicity
11/09/2011	CN102232958A Method for reducing daunorubicin cytotoxicity
11/09/2011	CN102232957A Antitumor activities of 3-acetoxyl-8,24-lanostadiene-21-acid and use of 3-acetoxyl-8, 24-lanostadiene-21-acid in medicines
11/09/2011	CN102232947A New application of epigallocatechin gallate (EGCG)
11/09/2011	CN102232946A Antrodia camphorata cyclohexenone compound for inhibiting stomach cancer tumor cell growth
11/09/2011	CN102232945A Antrodia camphorata cyclohexenone compound for suppressing growth of bladder cancer tumor cells
11/09/2011	CN102232944A Antrodia cinnamomea pimelie kelone compound for inhibiting growth of oral cancer tumor cells
11/09/2011	CN102232943A Antrodia camphorata cyclohexenone compound for inhibiting skin cancer tumor cell growth
11/09/2011	CN102232942A Antrodia camphorata cyclohexenone compound for suppressing growth of lymphoma tumor cells
11/09/2011	CN102232941A Antrodia camphorata cyclohexenone compound for inhibiting ovarian cancer tumor cell growth
11/09/2011	CN102232940A Antrodia camphorata cyclohexenone compound for inhibiting colorectal cancer tumor cell growth
11/09/2011	CN102232933A Tumor-targeting albumin nano-lyophilized powder injection preparation and preparation method thereof
11/09/2011	CN102232932A Pectin-adriamycin coniuncate lyophilized preparation, and preparation method thereof
11/09/2011	CN102232927A Vincristine-PEG-PLGA segmented copolymer nanoparticle, its preparation method and use
11/09/2011	CN102232926A Oral taxol nanoparticles and preparation method thereof
11/09/2011	CN102232922A Preparation method of ginsenoside Rg1 injection preparation
11/09/2011	CN102232553A Nutrient absorbing composition
11/09/2011	CN102232449A Wild chrysanthemum healthy tea granules
11/09/2011	CN102058854B Chinese medicine for treating malignant lymphoma
11/09/2011	CN101982196B Traditional Chinese medicine composition for treating lung cancer, preparation method and application thereof
11/09/2011	CN101966310B Traditional Chinese medicine for treating lung cancer
11/09/2011	CN101953845B Hepatic artery chemoembolization embolism agent containing autophagy inhibitor
11/09/2011	CN101904968B Preparation method of Chinese paris rhizome yam type saponin and anti-tumor medicinal preparation thereof
11/09/2011	CN101891811B Shark angiogenesis inhibiting factor and production and purification method and application
11/09/2011	CN101857584B Hydroxyl flavanoid compound and application thereof
11/09/2011	CN101849934B Phosphatidylinositol-3-kinase inhibitor and application thereof
11/09/2011	CN101829046B Amphipathilic block polymer micelle nano medicament carrying system and preparation method
11/09/2011	CN101805351B Fungi epoxy diene acid derivative 4-NDM and synthesis method and purpose thereof
11/09/2011	CN101804096B Method for extracting purified total alkaloid of strychnos nux-vomica and application thereof in pharmacy
11/09/2011	CN101791307B Application of 2-imino-phenylate-5-(2-hydroxy-benzyl)-1,3-thiazole-4-ketone in preparing anti-cerebral cancer medicaments
11/09/2011	CN101757571B Externally-applied traditional Chinese medicine composition for treating brain tumor and preparation method thereof
11/09/2011	CN101735238B Antitumor drug (hydroxyl morpholine) and derivative thereof as well as preparation method and application thereof
11/09/2011	CN101716280B Medicine composite used for curing liver cancer
11/09/2011	CN101716172B Application of miltipolone or pharmaceutically acceptable salts thereof in pharmacy
11/09/2011	CN101708156B Camptothecin medicament injection solution and injection and preparation method thereof
11/09/2011	CN101704891B Antibody for epidermal growth factor receptor, encoding gene thereof and application thereof
11/09/2011	CN101647970B Extractive of compound formula of ophiopogon decoction and caper euphorbia seed and reed stem soup and application thereof in preparing medicament for inhibiting H460 cell proliferation
11/09/2011	CN101597290B Beta-carboline-3-formyl tryptophyl amine acid carbamate as well as preparation method and application thereof
11/09/2011	CN101579496B Application of Chinese medicine composition in preparation of medicine for treating atypical hyperplasia of gastric mucosa
11/09/2011	CN101554409B Long pepper alkaloid and preparation method, preparation and application thereof
11/09/2011	CN101544953B Oxytropis Ehrig cinerea FEL2-OG and separation method and application thereof
11/09/2011	CN101536982B Trastuzumab-modified toxin protein-coated PEG immune liposome and preparation and application thereof
11/09/2011	CN101502503B Application of fluorobenzene salicylamide compound in preparing anti-tumor medicament
11/09/2011	CN101497608B HIV protease inhibitor derivative, preparation thereof and use in antineoplastic medicament preparation
11/09/2011	CN101454296B Derivatives of 2-alkoxy-3,4,5-trihydroxy-alkyl amides, preparation and use thereof, and compositions containing the same
11/09/2011	CN101405275B Triazolone derivative
11/09/2011	CN101392026B Polypeptide for preventing and treating fibrotic disease and liver cancer
11/09/2011	CN101365449B Nanoparticulate benzothiophene formulations
11/09/2011	CN101300231B Pyridylsulfonamide derivatives, their manufacture and use as antineoplastic agents
11/09/2011	CN101269087B Pectin-5-efudix colon cancer double-target prodrug and preparation method
11/09/2011	CN101265298B Endothelium chalone mutant containing non-natural amino acid and derivatives thereof
11/09/2011	CN101217971B Treatment of tumors
11/08/2011	US8053583 Anti-cancer compound and manufacturing method thereof
11/08/2011	US8053558 Dendritic cell co-stimulatory molecules
11/08/2011	US8053469 comprises a carrier essentially formed of water, ethoxydiglycol and propylene glycol; anti-oxidant; high stirring speed provides for micronizaton of the components, which is responsible for the stability of the solutions
11/08/2011	US8053453 Pyrazolone compounds and thrombopoietin receptor activator
11/08/2011	US8053434 Kinase inhibitors and their uses
11/08/2011	US8053414 Methods of using B7-DC molecules to induce or enhance an immune response
11/08/2011	US8053408 Methods for treating obesity using fibroblast growth factor-like polypeptides
11/08/2011	US8052981 Mono- and disaccharide derivatives
11/08/2011	CA2665048C Crystalline forms of thiazolidinedione compound and its manufacturing method
11/08/2011	CA2630262C The use of isothiocyanates compounds in treating prostatic diseases and skin cancer
11/08/2011	CA2499639C Imidazopyridines as cyclin dependent kinase inhibitors
11/08/2011	CA2493690C Synthetic c-glycolipid and its use for treating cancer, infectious diseases and autoimmune diseases
11/08/2011	CA2493436C Indolinone derivatives, substituted in the 6-position, their preparation and their use as medicaments
11/08/2011	CA2459230C Peptidic compounds selectively binding to p-selectin
11/08/2011	CA2436180C Immunoregulatory antibodies and uses thereof
11/08/2011	CA2431675C Novel sulfamides and their use as endothelin receptor antagonists
11/08/2011	CA2405408C Pyrazole compounds
11/08/2011	CA2362204C Immunogenic complexes and methods relating thereto
11/08/2011	CA2153692C Recombinant anti-vla4 antibody molecules
11/03/2011	WO2011137418A1 Selective integrin inhibitors
11/03/2011	WO2011137342A1 Cyclopropyl dicarboxamides and analogs exhibiting anti-cancer and anti-proliferative activites
11/03/2011	WO2011137319A2 Stabilized fibronectin domain compositions, methods and uses
11/03/2011	WO2011137274A1 Pharmaceutical compositions comprising n-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-l-(4-fluorophenyl)-2-oxo- 1,2-dihydropyridine-3 -carboxamide
11/03/2011	WO2011137155A1 Imidazopyridazinyl compounds and their uses for cancer
11/03/2011	WO2011137089A1 Activators of human pyruvate kinase
11/03/2011	WO2011136828A1 Immunogenic compositions and methods for treating neoplasia
11/03/2011	WO2011136744A1 Eif4e binding peptides
11/03/2011	WO2011136691A1 Diindolylmethane-based drug for the treatment of hyperplastic and inflammatory diseases

1 ... 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 ... 2211